Non-invasive liquid biopsy of the small airways is now a reality
Early detection and timely treatment are critical for improving patient outcomes across almost all diseases. This has motivated PExA, an innovation-led company based in Gothenburg, to develop a unique instrument for non-invasive sampling of the deepest part of the lung where lung diseases often initiate and develops to a non-curable state before giving symptoms. »